CpG oligodeoxynucleotides stimulate canine and feline immune cell proliferation.
Oligodeoxynucleotides (ODNs) with unmethylated CpG dinucleotide motifs may be useful as non-specific immune system stimulants and adjuvants for protein or nucleic acid vaccines in humans and other primates. They may also be useful in cancer immunotherapy and in the modulation of allergic responses or mucosal immunity. To begin to determine the potential utility of CpG ODN technology in small animal veterinary medicine, we developed procedures to analyze the effects of CpG ODN on canine and feline blood, spleen and lymph node (LN) cells. We find that certain CpG ODN cause good lymphocyte proliferation (as monitored by [(3)H]-thymidine incorporation) in both canine and feline spleen and LN cells, but not in blood. This overall stimulatory effect of CpG ODN on spleen and LN cells is CpG dependent. The reverse sequences, GpC ODNs, do not cause significant lymphocyte proliferation in the cat; however, dogs are more sensitive to stimulation by the non-specific immune effects of the phosphorothioate backbone. We conclude that unmethylated CpG ODNs may also have potential uses as immune stimulants for vaccines and other antimicrobial agents in veterinary medicine for companion animals.
Wernette
Catherine M
CM
Scott-Ritchey Research Center, College of Veterinary Medicine, Auburn University, Auburn, AL 36849-5525, USA. werneca@vetmed.auburn.edu
Smith
Bruce F
BF
Barksdale
Zachary L
ZL
Hecker
Rolf
R
Baker
Henry J
HJ
D000276:Adjuvants, Immunologic / Q000737:chemistry / Q000494:pharmacology*; D000818:Animals; D001483:Base Sequence; D002415:Cats / Q000276:immunology*; D002455:Cell Division / Q000187:drug effects; D018899:CpG Islands; D004285:Dogs / Q000276:immunology*; D005434:Flow Cytometry; D066298:In Vitro Techniques; D008198:Lymph Nodes / Q000166:cytology / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects*; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D009838:Oligodeoxyribonucleotides / Q000737:chemistry / Q000276:immunology / Q000494:pharmacology*; D013154:Spleen / Q000166:cytology / Q000276:immunology; D014612:Vaccines / Q000008:administration & dosage
D000276:Adjuvants, Immunologic; D009838:Oligodeoxyribonucleotides; D014612:Vaccines